A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles Tendinopathy
Clinical trial NCT05592990 · COMPLETED
Trial details
- NCT number
- NCT05592990
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-14
- Primary completion
- 2026-02-03
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.